Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAMMATE Trial: Everolimus and Low Dose Tacrolimus vs Tacrolimus and Mycophenolate Mofetil in Pediatric Heart Transplantation
NCT03386539Phase 3Completed
- Sponsor
- Boston Children's Hospital
- Start
- Jan 2018
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in heart transplant rejection, cardiac allograft vasculopathy (CAV), chronic kidney disease (CKD), sponsored by Boston Children's Hospital. Started Jan 2018; status: completed.
02
Drugs
everolimus
03
Conditions
heart transplant rejectioncardiac allograft vasculopathy (CAV)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03386539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386539.